1Wolf PA, Dawber TR, Thomas HE Jr, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study[J]. Neurology, 1978, 28(10): 973-977.
3Ott A, Breteler MM, de Bruyne MC, et al. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study[J]. Stroke, 1997, 28(2): 316-321.
4Hu D, Sun Y. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China[J]. J Am Coil Cardiol, 2008, 52(10): 865-868.
5Mattle HP. Long-term outcome after stroke due to atrial fibrillation[J]. Cerebrovasc Dis, 2003, 16(Suppl 1): 3-8.
6Mattle HP, Schwerzmann M, Seiler C. Atrial fibrillation and stroke[J]. Ther Umsch, 2003, 60(9): 527-534.
7Dobrev D. Electrical remodeling in atrial fibrillation[J]. Herz, 2006, 31(2): 108-112.
8Wijffels MC, Kirchhof CJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats[J]. Circulation, 1995, 92(7): 1954-1968.
9Brundel B J, Van Gelder IC, Henning RH, et al. Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels[J]. J Am Coll Cardiol, 2001, 37(3): 926-932.
10Dobrev D, Wettwer E, Kortner A, et al. Human inward rectifierPotassium channels in chronic and postoperative atrial fibrillation[J]. Cardiovase Res, 2002, 54(2): 397-404.
3Arstall MA,Sawyer DB,Fukazawa R,et al.Cytokine-mediated apoptosis in cardiac myocytes:the role of inducible nitric oxide synthase induction and peroxynitrite generation.Circ Res,1999,85:829-840.
4Singh JP,Adams LD,Bonin PD.Mode of fibroblast growth enhancement by human interleukin-1.J Cell Biol,1988,106:813-819.
5Gurantz D,Cowling RT,Varki N,et al.IL-1 beta and TNF-alpha upregulate angiotensin Ⅱ type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the postMI heart.J Mol Cell Cardiol,2005,38:505-515.
6Allessie M,Ausma J,Schotten U.Electrical,contractile and structural remodeling during atrial fibrillation.Cardiovasc Res,2002,54:230-246.
7Mann DL.Inflammatory mediators and the failing heart:past,present,and the foreseeable future.Circ Res,2002,91:988-998.
8Shioi T,Matsumori A,Kihara Y,et al.Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload.Circ Res,1997,81:664-671.
9Ausma J,van der Velden HM,Lenders MH,et al.Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat.Circulation,2003,107:2051-2058.
10Xu J,Cui G,Esmailian F,et al.Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation.Circulation,2004,109:363-368.
8Karras S,Tzotzas T,Kaltsas T,et al. Pharmacological treatment of hyper-thyroidism during lactation : review of the literature and novel data [J].Pediatr Endocrinol Rev,2010,8( 1) :25-33.
9Ghandour A, Heust C. Hyperthyroidism : a stepwise approach to man-agement [J]. J Fam Pract,2011,60(7);388-395.
10Mansourian AR. A review of literature on the adverse effects of hy-perthyroidism on the heart functional behavior [J]. Pak J Biol Sci,2012,15(4):164-176.
